Just listened to the CFO of CSL David Lamont on ASX CEO Connect....

Just listened to the CFO of CSL David Lamont on ASX CEO Connect. He said there is no intention on doing a share split because there is no need to, he also pointed to the cost of undertaking one which was not ideal. The number of shareholders are not decreasing, rather, they are increasing.

I also asked a question regarding the issues regarding plasma collection in the US in the Q & A.

He said that the main concern with plasma donors is their health and safety during the donation process. The plasma collection centres remain an essential service and are still open. He mentioned the usual COVID-19 precautions of sanitisation and social distancing within the plasma collection centres as mitigation strategies and he said that the donors are returning back.
He said that the plasma collection constraints ONLY pertain to the IG side of the business. Elsewhere is NOT affected.
With reference to the guidance for FY 21 of 0% - 8%(thereabouts) he mentioned that the 0% of growth scenario is if the plasma collection rates in the US stay within the rates noticed in the July 20 month.
He also said that as the economy in the US starts to "falter", he expects the number of donors to increase because of the financial incentives provided to the donors.